Literature DB >> 10516804

The presence of lupus anticoagulant and anticardiolipin antibodies in patients undergoing long-term neuroleptic treatment.

M Schwartz, M Rochas, E Toubi, B Sharf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10516804      PMCID： PMC1189039     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  8 in total

1.  Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.

Authors:  K N Chengappa; A B Carpenter; M S Keshavan; Z W Yang; R H Kelly; B S Rabin; R Ganguli
Journal:  Biol Psychiatry       Date:  1991-10-01       Impact factor: 13.382

2.  The antiphospholipid/cofactor syndromes.

Authors:  D Alarcón-Segovia; A R Cabral
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

3.  The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.

Authors:  P Thiagarajan; V Pengo; S S Shapiro
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

4.  High association of anticardiolipin antibodies with psychosis.

Authors:  M Schwartz; M Rochas; B Weller; A Sheinkman; I Tal; D Golan; N Toubi; I Eldar; B Sharf; D Attias
Journal:  J Clin Psychiatry       Date:  1998-01       Impact factor: 4.384

5.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

6.  Neuroleptic-associated autoantibodies. A prevalence study.

Authors:  R T Canoso; R M de Oliveira; R A Nixon
Journal:  Biol Psychiatry       Date:  1990-04-15       Impact factor: 13.382

7.  Anticardiolipin antibodies are elevated in drug-free, multiply affected families with schizophrenia.

Authors:  M Firer; P Sirota; K Schild; A Elizur; H Slor
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

8.  Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis.

Authors:  R T Canoso; R M de Oliveira
Journal:  Am J Hematol       Date:  1988-04       Impact factor: 10.047
  8 in total
  2 in total

Review 1.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

Review 2.  Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.

Authors:  Anna K Jönsson; Johan Schill; Hans Olsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.